Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a 'Trust Hormone' spray help ease the social isolation of schizophrenia?

NCT ID NCT06136390

Summary

This study tested whether using a nasal spray containing oxytocin, sometimes called the 'social hormone,' before group therapy sessions could help reduce specific symptoms of schizophrenia. Forty-two participants with schizophrenia received either the oxytocin spray or a placebo spray before weekly mindfulness-based group therapy. Researchers measured if this combination was better than therapy alone at reducing symptoms like social withdrawal, lack of motivation, and reduced emotional expression.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA SPECTRUM DISORDERS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Charité Universitätsmedizin Berlin, Campus Benjamin Franklin

    Berlin, State of Berlin, 12203, Germany

Conditions

Explore the condition pages connected to this study.